Skip to main content
Log in

Antilaminaribioside and antichitobioside antibodies in inflammatory bowel disease

  • Papers
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Testing antilaminaribioside (ALCA) and antichitobioside (ACCA) antibodies in 89 Crohn’s disease (CD), 31 ulcerative colitis (UC) and 50 controls, mean values were 38.6 and 53.0 ELISA units for CD, 34.0 and 32.6 for UC, 34.5 and 36.4 for controls, respectively. There was no significant difference of ALCA values between CD and UC (p = 0.401), CD and control subjects (p = 0.698) or UC and controls (p = 0.898). ACCA were significantly higher in CD compared with UC (p = 0.011) but not with the controls (p = 0.095). No significant difference of ACCA values between UC and controls (p = 0.107) was found. ALCA and ACCA values significantly correlated in CD (r = 0.548, p < 10−4) and UC (r = 0.885, p < 10−4) but not in controls (r = 0.153, p = 0.287). The positive predictive value for CD was only 20 (ALCA) and 8 % (ACCA), the negative ones (to exclude CD) 25 (ALCA) and 86 % (ACCA). Small and/or large bowel involvement or disease type (i.e. stenosing, perforating or inflammatory) of CD did not differ in the two values. The idea that ALCA and ACCA may be useful either to differentiate between CD, UC and healthy subjects or to stratify CD was not confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACCA:

antichitobioside antibodies

EU:

ELISA unit

ALCA:

antilaminaribioside antibodies

IBD:

inflammatory bowel disease

AMCA:

antimannobioside antibodies

pANCA:

antineutrophil cytoplasmic antibodies

ASCA:

anti-Saccharomyces cerevisiae antibodies

UC:

ulcerative colitis

CD:

Crohn’s disease

References

  • Altstock R.T., Shtevi A., Karban A., Dotan N., Halpern Z., Dotan I.: Improved IBD diagnosis via ELISA detecting novel antibodies: antichitobioside carbohydrate antibodies (ACCA), antilaminaribioside carbohydrate antibodies (ALCA) and antimannobioside carbohydrate antibodies (AMCA). Gastroenterology 128, A303 (2005).

    Google Scholar 

  • Dotan I., Fishman S., Kariv R., Dgani Y., Schwartz M., Gargir A., Spector L., Altstock R., Halpern Z., Dotan N.: Antilaminarobioside carbohydrate antibodies (ALCA) and antichitobiose carbohydrate antibodies (ACCA) are novel serologic markers specific for Crohn’s disease. Gastroenterology 125(Suppl. 2), A203 (2004).

    Google Scholar 

  • Dotan I., Fishman S., Dgani Y., Schwartz M., Karban A., Lerner A., Weishauss O., Spector L., Shtevi A., Altstock R.T., Dotan N., Halpern Z.: Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology 131, 366–378 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., Norman G., Altstock R., Van Steen K., Rutgeerts P., Van Assche G., Vermeire S.: New serological markers in inflammatory bowel disease are associated with complicated disease behavior. Gut 56, 1394–1403 (2007).

    Article  PubMed  Google Scholar 

  • Glycominds: IBDX ALCA IgG kit and IBDX ACCA IgA kit. Instructions for Use, version 06. Glycominds Ltd., Lod (Israel) 2006.

  • Lawrance I.C., Murray K., Hall A., Sung J.J., Leong R.: A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am.J.Gastroenterol. 99, 2186–2194 (2004).

    Article  PubMed  Google Scholar 

  • Main J., Mckenzie H., Kerr M.A., Robson D., Pennigton C.R., Parrat D.: Antibody to Sacharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. Brit.Med.J. 297, 1105 (1998).

    Article  Google Scholar 

  • Malíčková K., Lukáš M., Donoval R., Šandová P., Janatková I.: Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice? Clin.Lab. 52, 631–638 (2006).

    PubMed  Google Scholar 

  • Peeters M., Joossens S., Vermeire S., Vlietinck R., Bossuyt X., Rutgeerts P.: Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am.J.Gastroenterol. 96, 730–734 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Peppercon M.A.: Clinical manifestation and diagnosis of Crohn’s disease in adults. UpToDate, Vol. 15.3. Wellesley (2007); http://www.uptodate.com/ .

  • Ruemmele F.M., Targan S.R., Levy G., Dubinsky M., Braun J., Seidman E.G.: Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115, 822–829 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Vermeire S., Joossens S., Peeters M., Monsuur F., Marien G., Bossuyt X., Groenen P., Vlietinck R., Rutgeerts P.: Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 120, 827–833 (2001).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Rejchrt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rejchrt, S., Drahošová, M., Kopáčová, M. et al. Antilaminaribioside and antichitobioside antibodies in inflammatory bowel disease. Folia Microbiol 53, 373–376 (2008). https://doi.org/10.1007/s12223-008-0058-2

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-008-0058-2

Keywords

Navigation